Celgene raises 2013 forecast as profit beats estimates

(Reuters) - Celgene Corp raised its earnings forecast for 2013 on Thursday after reporting slightly higher-than-expected quarterly profit on robust sales of its flagship blood cancer drug Revlimid and rapid growth in newer cancer treatments.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news